Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Anticancer Research|August 15, 1998
Increased p21/WAF-1 and p53 protein levels following sequential three drug combination regimen of fludarabine, cytarabine and docetaxel induces apoptosis in human leukemia cellsV I Avramis, P Nandy, R Kwock, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1996
Specificity of neuropsychological impairment in obsessive-compulsive disorder: a comparison with social phobic and normal control subjectsL J Cohen, E Hollander, C M DeCaria, et al.
Psychiatry Research|September 29, 1995
Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazineD Simeon, E Hollander, D J Stein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancerC P Belani, A Einzig, P Bonomi, et al.
Clinical Lung Cancer|January 22, 2004
Docetaxel and cisplatin in patients with advanced non small-cell lung cancer (NSCLC): a multicenter phase II trialC P Belani, P Bonomi, T W Dobbs, et al.
Biological Psychiatry|September 15, 1993
Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCDE Hollander, L J Cohen, C DeCaria, et al.
American Journal of Hematology|December 1, 1995
Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: a summary of case reportsL J Cohen, N B McWilliams, R Neuberg, et al.
Archives of Pathology & Laboratory Medicine|September 1, 1996
Conventional versus modified morphologic criteria for ganglioneuroblastoma. A review of cases from the Pediatric Oncology GroupV V Joshi, A B Cantor, G Altshuler, et al.
Investigational New Drugs|November 9, 2014
A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumorsP P Peethambaram, L C Hartmann, D J Jonker, et al.
Pageof 4